Screening of small molecules affecting mammalian P-body assembly uncovers links with diverse intracellular processes and organelle physiology

RNA Biol. 2013 Nov;10(11):1661-9. doi: 10.4161/rna.26851.

Abstract

Processing bodies (P-bodies) are cytoplasmatic mRNP granules containing non-translating mRNAs and proteins from the mRNA decay and silencing machineries. The mechanism of P-body assembly has been typically addressed by depleting P-body components. Here we apply a complementary approach and establish an automated cell-based assay platform to screen for molecules affecting P-body assembly. From a unique library of compounds derived from myxobacteria, 30 specifically inhibited P-body assembly. Gephyronic acid A (GA), a eukaryotic protein synthesis inhibitor, showed the strongest effect. GA also inhibited, under stress conditions, phosphorylation of eIF2α and stress granule formation. Other hits uncovered interesting novel links between P-body assembly, lipid metabolism, and internal organelle physiology. The obtained results provide a chemical toolbox to manipulate P-body assembly and function.

Keywords: P-body assembly; eIF2α; gephyronic acid A; inhibitors; myxobacterial metabolites; processing bodies; stress granules.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Cycloheximide / pharmacology
  • Cytoplasmic Granules / drug effects
  • Cytoplasmic Granules / metabolism*
  • Drug Discovery*
  • Eukaryotic Initiation Factor-2 / metabolism
  • Fatty Acids, Monounsaturated / pharmacology
  • HeLa Cells
  • Humans
  • Lipid Metabolism
  • Myxococcales / chemistry*
  • Myxococcales / metabolism
  • Phosphorylation
  • Puromycin / pharmacology
  • RNA Stability
  • Ribonucleoproteins, Small Cytoplasmic / metabolism*
  • Small Molecule Libraries*

Substances

  • Eukaryotic Initiation Factor-2
  • Fatty Acids, Monounsaturated
  • Ribonucleoproteins, Small Cytoplasmic
  • Small Molecule Libraries
  • gephyronic acid
  • Puromycin
  • Cycloheximide